Effects of FRAX+SARC-F Pre-screening on Preventing Fragility Fracture and Fall in Community-dwelling Older Adults
NCT ID: NCT04709393
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
2956 participants
INTERVENTIONAL
2021-05-07
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
NCT04960033
Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area
NCT02483286
Geriatric Health Exam Osteoporosis Screening
NCT01934387
PRevention of OsTEoporotiC FracTure 2 Pilot Study
NCT06134908
Mobile Device to Help FRAX® Screening
NCT01930656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-screening
Receiving FRAX+SARC-F questionnaire pre-screening results on estimated fracture risk
FRAX+SARC-F questionnaire pre-screening
Pre-screening group participants will receive the FRAX+SARC-F questionnaire pre-screening and be notified of the preliminary estimation of their future hip fracture risk before being invited to our DXA screening and fall-risk assessment.
Control
Not receiving FRAX+SARC-F questionnaire pre-screening preliminary results on estimated fracture risk
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FRAX+SARC-F questionnaire pre-screening
Pre-screening group participants will receive the FRAX+SARC-F questionnaire pre-screening and be notified of the preliminary estimation of their future hip fracture risk before being invited to our DXA screening and fall-risk assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* living in the community
Exclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Timothy Kwok
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Kwok
Role: PRINCIPAL_INVESTIGATOR
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020.609-T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.